SEC Tracker
Get the app

Helus Pharma HELP

Helus Pharma announces investor event on Oct 21

Foreign issuer report

Form
6-K
Filed
Importance
Routine
  1. Hosts investor presentation on Oct 21, 2026
  2. Discusses HLP003 (Phase 3 for MDD) and HLP004 (Phase 2 for GAD)
  3. Includes perspectives from key opinion leaders on mental health treatments

Written from the 6-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Helus Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX